Literature DB >> 20620550

Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells.

S Walther1, A Beiras-Fernandez, C Csapo, S Münzing, C G Stief, C Hammer, B Reichart, E Thein.   

Abstract

OBJECTIVES: Polyclonal antithymocyte globulins (ATGs) are immunosuppressive agents applied for the treatment and prevention of organ rejection after transplantation. ATGs induce complement-mediated cell death in T lymphocytes and decrease leukocyte adhesion. However, little is known about the effects of ATGs on endothelial cells (EC). Our aim was to study the influence of ATGs upon the expression of adhesion molecules on human umbilical vein endothelial cells (HUVECs) after stimulation with tumor necrosis factor (TNF)-alpha.
MATERIAL AND METHODS: HUVECs obtained from umbilical cords were incubated with ATGs before and after 6-hour stimulation with TNF-alpha. The group incubated without ATG served as the controls. Another group was not stimulated with TNF-alpha. By flow cytometry, we analyzed the expression of several adhesion molecules: intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM), platelet EC adhesion molecule (PECAM), and CD62E. Statistical analysis used analysis of variance.
RESULTS: After TNF-alpha stimulation, the EC surface expression of ICAM-1 and CD62E was reduced, although not significantly, in treated as compared with untreated cells. The expression of ICAM-1 and CD62E was similar in the unstimulated groups. The expression of VCAM, PECAM, CD55, and CD58 was not modified by ATG treatment.
CONCLUSION: Our results demonstrated that ATGs insignificantly reduced the expression of adhesion molecules in HUVECs. The effect of ATGs on stimulated HUVECs remains unclear, probably due to the lack of effector cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620550     DOI: 10.1016/j.transproceed.2009.11.038

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity.

Authors:  Mohamad Mohty; Andrea Bacigalupo; Faouzi Saliba; Andreas Zuckermann; Emmanuel Morelon; Yvon Lebranchu
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?

Authors:  Lluís Guirado
Journal:  J Transplant       Date:  2018-07-12

3.  Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.

Authors:  Young Suk Lee; Eduardo Davila; Tianshu Zhang; Hugh P Milmoe; Stefanie N Vogel; Jonathan S Bromberg; Joseph R Scalea
Journal:  Innate Immun       Date:  2019-01       Impact factor: 2.680

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.